Muriel Heldring
PhD candidate / guest
- Name
- Dr. M.M. Heldring
- Telephone
- +31 71 527 2727
- m.m.heldring@lacdr.leidenuniv.nl
Muriel Heldring (M.Sc.) is a PhD student at the Division of Drug Discovery & Safety
PhD candidate / guest
- Science
- Leiden Academic Centre for Drug Research
- LACDR/Toxicology
- Zobl W., Bitsch A., Blum J., Boei J.J.W.A., Capinha L., Carta G., Castell J., Davoli E., Drake C., Fisher C.P., Heldring M.M., Islam B., Jennings P., Leist M., Pellegrino-Coppola D., Schimming J.P., Snijders K.E., Tolosa L., Water B. van de, Vugt-Lussenburg B.M.A. van, Walker P., Wehr M.M., Wijaya L.S. & Escher S.E. (2024), Protectiveness of NAM-based hazard assessment: which testing scope is required?, ALTEX - Alternatives to Animal Experimentation 41(2): 302-319.
- Heldring M.M. (12 December 2023), Integrating cellular and tissue dynamics with cell fate decisions through computational modeling (Dissertatie. Leiden Academic Centre for Drug Research (LADCR), Faculty of Science, Leiden University). Supervisor(s): Beltman J.B. & Water B. van de.
- Heldring M.M., Wijaya L.S., Niemeijer M.C., Yang H., Lakhal T., Le Dévédec S.E., Water B. van de & Beltman J.B. (2022), Model-based translation of DNA damage signaling dynamics across cell types, PLoS Computational Biology 18(7): e1010264.
- Heldring M.M., Shaw A.H. & Beltman J.B. (2022), Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury, npj Systems Biology and Applications 8(1): 27.